ADVERTISEMENT

Biologics for Psoriasis

Cutis. 2016 March;97(3):
Author and Disclosure Information

As part of our commitment to resident education, Cutis is excited to offer this monthly section with board-relevant, easy-to-review material.

This study material discusses the current US Food and Drug Administration–approved biologic medications for psoriasis and psoriatic arthritis, including the mechanism of action, dosing, and side effects.

5. Which biologic has been shown to cause reversible posterior leukoencephalopathy syndrome?

a. adalimumab

b. etanercept

,

c. infliximab

d. secukinumab

e. ustekinumab

Answers to practice questions provided on next page